Nuvectis Pharma Net Tangible Assets

Nuvectis Pharma (NVCT) currently reports a net tangible assets of $130M as of September 2026. That compares with $24M in the prior-year period — up 427.5% year over year. Use the charts on this page to explore Nuvectis Pharma's net tangible assets history and peer comparisons.

Nuvectis Pharma's net tangible assets increased from $24M to $130M — a 427.5% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nuvectis Pharma reported $130M in net tangible assets as of September 2026. That compares with $24M in the prior-year period — up 427.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nuvectis Pharma, and consider following NVCT for alerts when major investors trade the stock.